{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:16:38Z","timestamp":1790648198236,"version":"4.1.0"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamaoncol.2020.0007","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T15:31:57Z","timestamp":1584027117000},"page":"744","source":"Crossref","is-referenced-by-count":66,"title":["Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Esther","family":"Pohl-Rescigno","sequence":"first","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hauke","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"M\u00f6bus","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Hematology and Oncology, University of Frankfurt, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Philipps-Universit\u00e4t Marburg und Universit\u00e4tsklinikum Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Fasching","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Kayali","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Ernst","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Weber-Lassalle","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Hanusch","sequence":"additional","affiliation":[{"name":"Rotkreuzklinikum M\u00fcnchen, Frauenklinik, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Tesch","sequence":"additional","affiliation":[{"name":"H\u00e4matologisch-Onkologische Gemeinschaftspraxis, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Altm\u00fcller","sequence":"additional","affiliation":[{"name":"Cologne Center for Genomics, University of Cologne, Cologne, Germany"},{"name":"Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[{"name":"Cologne Center for Genomics, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Untch","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"L\u00fcbbe","sequence":"additional","affiliation":[{"name":"Breast Center, Diakovere Henriettenstift, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"N\u00fcrnberg","sequence":"additional","affiliation":[{"name":"Cologne Center for Genomics, University of Cologne, Cologne, Germany"},{"name":"Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany"},{"name":"Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Furlanetto","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Lederer","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jackisch","sequence":"additional","affiliation":[{"name":"Sana Klinikum Offenbach GmbH, Offenbach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nekljudova","sequence":"additional","affiliation":[{"name":"German Breast Group, Neu-Isenburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita K.","family":"Schmutzler","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schneeweiss","sequence":"additional","affiliation":[{"name":"National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hahnen","sequence":"additional","affiliation":[{"name":"Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Cologne, Faculty of Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"cbr200001r1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejca.2018.10.015","article-title":"Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): a randomised phase III trial.","volume":"106","author":"Schneeweiss","year":"2019","journal-title":"Eur J Cancer"},{"issue":"10","key":"cbr200001r2","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1001\/jamaoncol.2017.1007","article-title":"Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the GeparSixto randomized clinical trial.","volume":"3","author":"Hahnen","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"cbr200001r3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000455999","article-title":"Germline mutations in triple-negative breast cancer.","volume":"12","author":"Hahnen","year":"2017","journal-title":"Breast Care (Basel)"},{"issue":"8","key":"cbr200001r4","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.molonc.2015.04.011","article-title":"BRCA1-like signature in triple negative breast cancer: molecular and clinical characterization reveals subgroups with therapeutic potential.","volume":"9","author":"Severson","year":"2015","journal-title":"Mol Oncol"},{"issue":"3","key":"cbr200001r5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10549-016-3697-z","article-title":"Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.","volume":"155","author":"Evans","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"cbr200001r6","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk.","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"cbr200001r7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2016.5592","article-title":"Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer.","volume":"3","author":"Neidhardt","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"cbr200001r8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cam4.2018.7.issue-4","article-title":"Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.","volume":"7","author":"Hauke","year":"2018","journal-title":"Cancer Med"},{"issue":"2","key":"cbr200001r9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-014-3100-x","article-title":"Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients.","volume":"147","author":"Byrski","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"cbr200001r10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-018-0009-7","article-title":"Carboplatin in BRCA1\/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT trial.","volume":"24","author":"Tutt","year":"2018","journal-title":"Nat Med"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2762579\/jamaoncology_pohlrescigno_2020_br_200001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:26:26Z","timestamp":1589513186000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2762579"}},"subtitle":["A Secondary Analysis of the GeparOcto Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.0007","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}